eMedicine Specialties > Pediatrics: General Medicine > Parasitology

Ancylostoma Infection

Author: Vinod K Dhawan, MD, FACP, FRCP(C), Professor, Department of Clinical Medicine, University of California at Los Angeles; Professor of Medicine, Charles R Drew University of Medicine and Science; Chief, Division of Infectious Diseases, MLK-Harbor Hospital
Coauthor(s): Swati Garekar, MBBS, Staff Physician, Department of Pediatrics, Children's Hospital of Michigan; Basim Asmar, MD, Director, Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Michigan; Professor, Department of Pediatrics, Wayne State University School of Medicine
Contributor Information and Disclosures

Updated: May 1, 2008

Introduction

Background

Hookworm is the common name for blood-sucking nematodes of the Ancylostomatidae family. The 2 species that most commonly infect humans are Ancylostoma duodenale and Necator americanus.

Members of the Ancylostoma genus cause the following 3 clinical entities in humans:

  • Classic hookworm disease is a GI infection with chronic blood loss that leads to iron deficiency anemia and protein malnutrition. The disease is caused by A duodenale, the major anthropophilic hookworm, and, less commonly, by the zoonotic species Ancylostoma ceylanicum.
  • Cutaneous larva migrans is an infection caused most commonly by larvae of Ancylostoma braziliense, whose definitive hosts include dogs and cats. The manifestations of cutaneous larva migrans are limited to the skin.
  • Eosinophilic enteritis is a GI infection caused by the dog hookworm Ancylostoma caninum.1 The disease is characterized by abdominal pain but no blood loss.

N americanus causes only classic hookworm disease, as defined above.

In 1880, an epidemic called miners' anemia occurred among Italian laborers building the Saint Gotthard railway tunnel in the Swiss Alps. A duodenale was responsible for the epidemic.

Pathophysiology

Eggs deposited on warm, moist soil develop into infective larvae over 5-7 days. Infective larvae are developmentally arrested and nonfeeding. If unable to infect a new host, the larvae die when their metabolic reserves are exhausted, usually in about 6 weeks. Humans are the major reservoir, and infection is maintained by continual contamination of soil by human feces.

Classic hookworm infection

The life cycle of hookworms is depicted in Media file 1. Humans acquire infection either by exposing skin to soil contaminated with A duodenale larvae or N americanus larvae or by ingesting soil contaminated with A duodenale larvae.

Eggs are passed in the stool undefined, and the larvae hatch in 1-2 days under favorable conditions (see Media file 2). The released rhabditiform larvae grow in the feces and/or soil undefined (see Media file 3). After 5-10 days, they become filariform larvae that are infective (see Media file 4). These infective larvae can survive for 3-4 weeks in favorable environmental conditions. 

Upon contact with the human host, the larvae penetrate the skin. The larvae elaborate a protease that helps the organisms bore through the skin. The larvae are carried through the veins to the heart and then to the lungs. They penetrate the pulmonary alveoli, ascend the bronchial tree to the pharynx, and are swallowed. During the migratory phase, larvae evoke an eosinophilic inflammatory response.

After passively reaching the proximal small intestine, larvae develop into adult, sexually mature male and female worms. The adult worm attaches with its mouth to the mucosa of the small intestine and begins to feed. The hookworm digests the tissue within its buccal capsule, using its teeth or cutting plates, powerful esophageal muscles, and hydrolytic enzymes. At the same time, the worm releases a potent anticoagulant, which causes profound bleeding from eroded capillaries in the lamina propria.

Larvae require about 6-8 weeks from the time of skin penetration to develop into adults. Worms mate in the small intestine, and the females deposit fertilized eggs into the lumen. Eggs begin to appear in feces about 8-12 weeks after infection. Worms change location every 4-8 hours, producing minute, bleeding, mucosal ulcerations. Adult worms are eliminated in 1-2 years, but longevity records can reach several years.

Following penetration of the host skin, some A duodenale larvae can become dormant (in the intestine or muscle). In addition, infection by A duodenale may also occur by the oral and transmammary route. However, N americanus requires a transpulmonary migration phase.

Larva migrans

The infective larvae of zoonotic species such as A braziliense do not elaborate sufficient concentrations of hydrolytic enzymes to penetrate the junction of the dermis and epidermis. These larvae remain trapped superficial to this layer, where they migrate laterally at a rate of 1-2 cm/d and create the pathognomonic serpiginous tunnels of cutaneous larva migrans. Larvae can survive in the skin for about 10 days before dying (even in untreated persons).

Eosinophilic enteritis

Larvae of A caninum typically enter a human host by skin penetration, although infection by oral ingestion is possible. These larvae probably remain dormant in skeletal muscles and create no symptoms.

In some individuals, larvae may reach the gut and mature into adult worms. Why some individuals sustain A caninum development and then respond with a severe localized allergic reaction is unknown.

Adult worms secrete various potential allergens into the intestinal mucosa. Some patients have been reported to have increasingly severe recurrent abdominal pain, which may be analogous to a response to repeated insect stings.

Frequency

United States

Classic hookworm infection is most common among travelers, immigrants, and adoptees from developing countries. A low prevalence of the infection, mainly due to N americanus, is still found in pockets of the southeastern United States.

Cutaneous larva migrans is endemic in the southeastern states and Puerto Rico. The dog hookworm, A caninum, has reportedly caused eosinophilic enteritis in Australia and the United States; increased human infections are anticipated because of the global distribution of dogs.

International

Human infection with A duodenale and N americanus is estimated to affect approximately one fourth of the world's population. These parasites drain the equivalent of all the blood from approximately 1.5 million people every day. Infection is most prevalent in tropical and subtropical zones, roughly between the latitudes of 45°N and 30°S. Hookworm infection occurs only in isolated temperate areas.

Infection is endemic in most developing countries. However, even in endemic regions, infection is usually confined to rural areas, especially where human feces are used as fertilizer or where sanitation is inadequate. In developed countries, infection is most commonly encountered in travelers, immigrants, and adoptees from developing countries.

A duodenale is the predominant species in the Mediterranean region, in northern regions of India and China, and in North Africa. A ceylanicum is found in focally endemic areas in southern Asia. N americanus is the predominant species in southern China, Southeast Asia, the Americas, most of Africa, and parts of Australia. This differential distribution is not absolute, and mixed infections with both species are common in individual patients.

Mortality/Morbidity

  • As is true with most helminthic infections in endemic areas, relatively few persons carry heavy parasite burdens, although hookworm disease may be fatal, especially in infants.
  • A single adult A duodenale causes about 0.2 mL of blood loss per day, and each adult N americanus causes about 0.02 mL blood loss per day.
  • The extent of infection may be categorized as light (ie, <100 worms), moderate (ie, 100-500 worms), or heavy (ie, 500-1000 worms). People who develop an initial heavy infection seem to reacquire heavy infection, and individuals who are lightly infected reacquire light infections, which suggests an underlying genetic susceptibility.
    • Individuals with light infection have minimal blood loss and may have infection but not disease, especially if iron intake or reserves are adequate to compensate for the blood loss.
    • Moderate-to-heavy infections cause iron deficiency anemia.
  • Hookworm anemia may be noted.
    • Hookworms are the leading cause of iron deficiency anemia in developing countries.
    • In one study involving 492 children, in children with N americanus, the prevalence of anemia and the prevalence of ferritin levels of less than 12 μ g/L were 60.5% and 33.1%, respectively; in children with A duodenale, the respective prevalences were 80.6% and 58.9%.2
    • The timing of anemia onset depends on the patient's preexisting iron stores.
    • Because iron is also required for the biosynthesis of neurotransmitters, anemia may affect cognitive development.
    • Significant anemia can cause growth and developmental delay.
  • Malabsorption may occur.
    • Heavy infections can cause significant protein loss as the host loses RBCs and plasma.
    • Adult hookworms also secrete a potent inhibitor of digestive enzymes, which may contribute to malabsorption.
    • Malabsorption leads to hypoproteinemia, which aggravates malnutrition.
    • Malabsorption is more common in children than in adults.
  • Anemia and protein malnutrition occur together in as many as 25% of infected individuals.

Sex

  • Both sexes are equally susceptible.

Age

  • In endemic areas, the highest prevalence is among school-aged children and adolescents, which may be because of age-related changes in exposure and the acquisition of immunity.
  • Once infected, children are more vulnerable to developing morbidity because dietary intake often fails to compensate for intestinal losses of iron and protein, especially in developing countries.
  • A fulminant form of acute GI hemorrhage associated with acute ancylostoma infection has been described in newborns.

Clinical

History

  • Acute stage of classic hookworm disease
    • Pruritus at the site of larval penetration (also called ground itch or dew itch) is proportionate to the number of infecting larvae. Infection with zoonotic hookworms, especially A braziliense, can progress with a lateral migration of larvae that results in cutaneous tracts of larva migrans.
    • Cough and wheezing can occur about one week after exposure and is due to larval migration through the lungs. Unlike that in ascariasis, pulmonary symptoms are uncommon and usually mild, except in severe infections.
    • An acute intestinal phase occurs in heavy infections and is characterized by abdominal pain, nausea, anorexia, and diarrhea that usually develops around one month after infection.
    • Wakana disease is characterized by nausea, vomiting, dyspnea, and eosinophilia and occurs after the oral ingestion of a large number of infective A duodenale larvae. This may represent a severe immediate hypersensitivitylike reaction to A duodenale antigens.
  • Chronic stage of classic hookworm disease
    • Moderate-to-heavy infections cause significant blood loss, which may manifest as melena. Once iron reserves are exhausted, anemia develops and causes symptoms such as fatigue and dyspnea upon exertion.
    • Deficits in physical and intellectual growth can occur, which may be irreversible when they occur during infancy.
  • Eosinophilic enteritis: This is characterized by repeated episodes of abdominal pain in approximately 97% of affected individuals. These episodes typically occur with increasing severity and are associated with peripheral eosinophilia in almost 100% of patients and with leukocytosis in approximately 75% of patients. Extreme cases may mimic appendicitis or intestinal perforation.

Physical

  • Acute stage of classic hookworm disease
    • Erythema with small papules or vesicles develops at the site of larval entry, typically on the feet, and usually persists for 1-2 weeks.
    • Intense scratching may lead to a secondary bacterial infection, which is quite common.
    • Scattered wheezing may be heard during larval migration through the pulmonary system.
  • Chronic stage of classic hookworm disease
    • Pallor, chlorosis (greenish yellow skin discoloration), tachycardia, and other signs of high-output cardiac failure are caused by anemia.
    • Edema is caused by hypoproteinemia.
    • Signs of malnutrition are evident.
  • Cutaneous larva migrans: This manifests as pathognomonic, raised serpiginous tracts ("creeping eruptions") with surrounding erythema that may last one month if untreated. Lesions are most commonly seen on lower extremities but may be limited to the trunk or upper extremities based on the site of entry of infective larvae.

Causes

  • Several Ancylostoma species cause disease in humans, such as the following:
    • A duodenale primarily infects humans and is responsible for classic hookworm disease.
    • A ceylanicum primarily infects animals but can cause milder classic hookworm disease in humans.
    • A braziliense and A caninum also primarily infect animals (eg, cats, dogs); humans are accidental hosts. Both species can cause cutaneous larva migrans, although most cases are caused by A braziliense. A caninum causes eosinophilic enteritis.
  • Hookworm microbiology includes the following:
    • Each adult A duodenale is about 1 cm in length. The buccal capsule of an adult worm has teeth to facilitate attachment to mucosa. A muscular esophagus creates suction in the buccal capsule.
    • Adult worms release hyaluronidase, which degrades intestinal mucosa and erodes blood vessels, resulting in blood extravasation. Worms also ingest some blood. An anticoagulant facilitates blood flow by blocking the activity of blood coagulation factors Xa and VIIa.
    • Adult worms also elaborate factors (eg, neutrophil inhibitory factor), which protect them from host defenses.
    • Each mature A duodenale female produces about 10,000-30,000 eggs daily; a female N americanus produces 5000-10,000 eggs daily. Under appropriate conditions, eggs develop into infective larvae.
    • Infective larvae are barely visible to the naked eye (ie, about 500-700 µm in length).
    • The natural life span is about one year for an adult A duodenale and 3-5 years for an adult N americanus.
    • The larvae's ability to enter a dormant state in the human host may be an adaptive response to increase the chances of propagation. If all larvae were to mature promptly during dry seasons of the year, females would release eggs onto inhospitable soil. Eggs produced and released during the wet season have a much greater chance of encountering optimal soil conditions for further development.
  • Environmental conditions include the following:
    • The optimal conditions for egg development in soil are ambient temperatures of 20-30°C and warm, moist, well-aerated soil that is shielded from sunlight. These conditions occur during cultivation of numerous agricultural products (eg, tea in India, mulberry leaves in China, coffee in Central and South America, rubber in Africa). Hence, hookworm infections occur primarily in rural areas.
    • Larvae fail to develop in temperatures below 13°C and are destroyed by temperatures below 0°C and above 45°C. Drying and direct sunlight also kill larvae.

More on Ancylostoma Infection

Overview: Ancylostoma Infection
Differential Diagnoses & Workup: Ancylostoma Infection
Treatment & Medication: Ancylostoma Infection
Follow-up: Ancylostoma Infection
Multimedia: Ancylostoma Infection
References

References

  1. Prociv P, Croese J. Human eosinophilic enteritis caused by dog hookworm Ancylostoma caninum. Lancet. Jun 2 1990;335(8701):1299-302. [Medline].

  2. Albonico M, Stoltzfus RJ, Savioli L, et al. Epidemiological evidence for a differential effect of hookworm species, Ancylostoma duodenale or Necator americanus, on iron status of children. Int J Epidemiol. Jun 1998;27(3):530-7. [Medline].

  3. Gasser RB, Cantacessi C, Loukas A. DNA technological progress toward advanced diagnostic tools to support human hookworm control. Biotechnol Adv. Jan-Feb 2008;26(1):35-45. [Medline].

  4. Jelinek T, Maiwald H, Nothdurft HD, Loscher T. Cutaneous larva migrans in travelers: synopsis of histories, symptoms, and treatment of 98 patients. Clin Infect Dis. Dec 1994;19(6):1062-6. [Medline].

  5. Caumes E, Datry A, Paris L. Efficacy of ivermectin in the therapy of cutaneous larva migrans. Arch Dermatol. Jul 1992;128(7):994-5. [Medline].

  6. de Silva N, Guyatt H, Bundy D. Anthelmintics. A comparative review of their clinical pharmacology. Drugs. May 1997;53(5):769-88. [Medline].

  7. Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000;121 Suppl:S113-32. [Medline].

  8. Kabatereine NB, Brooker S, Koukounari A, Kazibwe F, Tukahebwa EM, Fleming FM. Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren. Bull World Health Organ. Feb 2007;85(2):91-9. [Medline].

  9. Larocque R, Casapia M, Gotuzzo E, MacLean JD, Soto JC, Rahme E. A double-blind randomized controlled trial of antenatal mebendazole to reduce low birthweight in a hookworm-endemic area of Peru. Trop Med Int Health. Oct 2006;11(10):1485-95. [Medline].

  10. Diemert DJ, Bethony JM, Hotez PJ. Hookworm vaccines. Clin Infect Dis. Jan 15 2008;46(2):282-8. [Medline].

  11. Hughes RG, Sharp DS, Hughes MC. Environmental influences on helminthiasis and nutritional status among Pacific schoolchildren. Int J Environ Health Res. 2004;14(3):163-77.

  12. Bennett A, Guyatt H. Reducing intestinal nematode infection: efficacy of albendazole and mebendazole. Parasitol Today. Feb 2000;16(2):71-4. [Medline].

  13. Flohr C, Tuyen LN, Lewis S, Minh TT, Campbell J, Britton J. Low efficacy of mebendazole against hookworm in Vietnam: two randomized controlled trials. Am J Trop Med Hyg. Apr 2007;76(4):732-6. [Medline].

  14. American Academy of Pediatrics. Hookworm infection. In: 2000 Red Book: Report of the Committee on Infectious Diseases. 2000:321-2.

  15. Hochedez P, Caumes E. Hookworm-related cutaneous larva migrans. J Travel Med. Sep-Oct 2007;14(5):326-33. [Medline].

  16. Hotez PJ. Hookworm disease in children. Pediatr Infect Dis J. Aug 1989;8(8):516-20. [Medline].

  17. Hotez PJ, Brooker S, Bethony JM, et al. Hookworm infection. N Engl J Med. Aug 19 2004;351(8):799-807. [Medline].

  18. Hotez PJ, Pritchard DI. Hookworm infection. Sci Am. Jun 1995;272(6):68-74. [Medline].

  19. Kucik CJ, Martin GL, Sortor BV. Common intestinal parasites. Am Fam Physician. Mar 1 2004;69(5):1161-8. [Medline].

  20. Long SS, Pickering LK, Prober CG. Hookworm. In: Principles and Practice of Pediatric Infectious Diseases. 1997:1462-4.

  21. Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 2000:2941-2.

Further Reading

Keywords

hookworm infection, hookworm, hookworm disease, Ancylostomatidae, Ancylostoma duodenale, Necator americanus, Ancylostoma caninum, Ancylostoma ceylanicum, Ancylostoma braziliense, cutaneous larva migrans, eosinophilic enteritis, iron deficiency anemia, protein malnutrition, iron deficiency anemia, protein malnutrition, helminthic infections, hookworm anemia, malabsorption, hypoproteinemia, malnutrition, GI hemorrhage, ancylostoma infection, ground itch, dew itch, Wakana disease, melena, leukocytosis, erythema

Contributor Information and Disclosures

Author

Vinod K Dhawan, MD, FACP, FRCP(C), Professor, Department of Clinical Medicine, University of California at Los Angeles; Professor of Medicine, Charles R Drew University of Medicine and Science; Chief, Division of Infectious Diseases, MLK-Harbor Hospital
Vinod K Dhawan, MD, FACP, FRCP(C) is a member of the following medical societies: American College of Physicians, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, and Royal College of Physicians and Surgeons of Canada
Disclosure: Pfizer Inc None None

Coauthor(s)

Swati Garekar, MBBS, Staff Physician, Department of Pediatrics, Children's Hospital of Michigan
Swati Garekar, MBBS is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Basim Asmar, MD, Director, Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Michigan; Professor, Department of Pediatrics, Wayne State University School of Medicine
Basim Asmar, MD is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society
Disclosure: Nothing to disclose.

Medical Editor

Michael D Nissen, MBBS, BMedSc, FRACP, FRCPA, Associate Professor in Biomolecular, Biomedical Science & Health, Griffith University; Director of Infectious Diseases and Unit Head of Queensland Paediatric Infectious Laboratory, Sir Albert Sakzewski Viral Research Centre, Royal Children's Hospital
Michael D Nissen, MBBS, BMedSc, FRACP, FRCPA is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Pediatric Infectious Diseases Society, Royal Australasian College of Physicians, and Royal College of Pathologists of Australasia
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

Martin Weisse, MD, Program Director, Associate Professor, Department of Pediatrics, West Virginia University
Martin Weisse, MD is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Pediatric Infectious Diseases Society
Disclosure: Nothing to disclose.

CME Editor

Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility
Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Consulting; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching; sanofi pasteur Grant/research funds Unrestricted research grant; sanofi pasteur  Consulting; sanofi pasteur Honoraria Speaking and teaching; Tap Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association
Disclosure: None None None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.